Annual EBITDA
$851.39M$34.59M+4.23%
Summary
- Current Value
- As of today, ALGN annual EBITDA is $851.39M, up +4.23% on
- Historical Performance
- ALGN annual EBITDA is up +5.06% over the past 3 years, up +69.22% over the past 5 years
- All-Time High Comparison
- ALGN annual EBITDA is currently -23.43% below its historical high of $1.11B set on
- 3-Year Low Comparison
- ALGN annual EBITDA is +6.55% above its 3-year low of $799.06M reached on
- Sector Comparison
- ALGN annual EBITDA is higher than 92.85% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $851.39M | +4.2% | +5.1% | +69.2% | +654.8% | |
| Quarterly EBITDA | $241.56M | +38.5% | +36.4% | -6.0% | +821.9% | |
| TTM EBITDA | $918.54M | +14.2% | +22.1% | +38.4% | +701.0% | |
| Price | $163.04 | -5.2% | -44.0% | -72.5% | +580.2% | |
| PE Ratio | 27.32 | -12.7% | -62.1% | -73.4% | +10.6% | |
| Annual Revenue | $4.03B | +0.9% | +8.0% | +63.2% | +942.3% | |
| Annual EPS | $5.65 | +0.6% | +22.6% | -74.8% | +495.1% | |
| $616.22M | -8.3% | -5.8% | +59.2% | +524.9% | ||
| Annual Net Income | $410.35M | -2.6% | +13.5% | -76.9% | +452.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $851.39M | at high | |
| 5Y | $1.11B | -23.4% | |
| All | $1.11B | -23.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $799.06M | +6.5% | |
| 5Y | $503.14M | N/A | +69.2% |
| All | -$90.85M | +1037.1% |
EBITDA History
FAQ
What is the current annual EBITDA of ALGN?
As of today, ALGN annual EBITDA is $851.39M
What is 1-year change in ALGN annual EBITDA?
ALGN annual EBITDA is up +4.23% year-over-year
What is 3-year change in ALGN annual EBITDA?
ALGN annual EBITDA is up +5.06% over the past 3 years
How far is ALGN annual EBITDA from its all-time high?
ALGN annual EBITDA is currently -23.43% below its historical high of $1.11B set on December 31, 2021
How does ALGN annual EBITDA rank versus sector peers?
ALGN annual EBITDA is higher than 92.85% of companies in Healthcare sector
When is ALGN next annual earnings release?
As of today, the next annual earnings release for ALGN has not been scheduled
Quarterly EBITDA
$241.56M$20.03M-7.66%
Summary
- Current Value
- As of today, ALGN quarterly EBITDA is $241.56M, down -7.66% on
- Historical Performance
- ALGN quarterly EBITDA is up +38.49% year-over-year, up +36.40% over the past 3 years
- All-Time High Comparison
- ALGN quarterly EBITDA is currently -19.83% below its historical high of $301.30M set on
- 3-Year Low Comparison
- ALGN quarterly EBITDA is +38.49% above its 3-year low of $174.43M reached on
- Sector Comparison
- ALGN quarterly EBITDA is higher than 92.61% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $241.56M | -7.7% | +38.5% | +36.4% | -6.0% | |
| Annual EBITDA | $851.39M | – | +4.2% | +5.1% | +69.2% | |
| TTM EBITDA | $918.54M | +7.9% | +14.2% | +22.1% | +38.4% | |
| Price | $163.04 | -14.2% | -5.2% | -44.0% | -72.5% | |
| PE Ratio | 27.32 | -18.6% | -12.7% | -62.1% | -73.4% | |
| Quarterly Revenue | $1.04B | -0.7% | +6.2% | +10.3% | +16.2% | |
| Quarterly EPS | $1.57 | -16.8% | +24.3% | +38.3% | -37.3% | |
| $172.67M | -24.0% | +27.6% | +29.3% | -23.4% | ||
| Quarterly Net Income | $112.77M | -16.9% | +21.0% | +28.4% | -43.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $261.59M | -7.7% | |
| 3Y | $261.59M | -7.7% | |
| 5Y | $301.30M | -19.8% | |
| All | $301.30M | -19.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $174.43M | N/A | +38.5% |
| 3Y | $174.43M | +38.5% | |
| 5Y | $165.58M | +45.9% | |
| All | -$43.85M | +650.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ALGN?
As of today, ALGN quarterly EBITDA is $241.56M
What is ALGN quarterly EBITDA most recent change?
ALGN quarterly EBITDA was down -7.66% on March 31, 2026
What is 1-year change in ALGN quarterly EBITDA?
ALGN quarterly EBITDA is up +38.49% year-over-year
How far is ALGN quarterly EBITDA from its all-time high?
ALGN quarterly EBITDA is currently -19.83% below its historical high of $301.30M set on June 30, 2021
How does ALGN quarterly EBITDA rank versus sector peers?
ALGN quarterly EBITDA is higher than 92.61% of companies in Healthcare sector
When is ALGN next earnings release?
The next earnings release for ALGN is on
TTM EBITDA
$918.54M$67.13M+7.89%
Summary
- Current Value
- As of today, ALGN TTM EBITDA is $918.54M, up +7.89% on
- Historical Performance
- ALGN TTM EBITDA is up +14.23% year-over-year, up +22.11% over the past 3 years
- All-Time High Comparison
- ALGN TTM EBITDA is currently -17.34% below its historical high of $1.11B set on
- 3-Year Low Comparison
- ALGN TTM EBITDA is +23.84% above its 3-year low of $741.73M reached on
- Sector Comparison
- ALGN TTM EBITDA is higher than 92.80% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $918.54M | +7.9% | +14.2% | +22.1% | +38.4% | |
| Annual EBITDA | $851.39M | – | +4.2% | +5.1% | +69.2% | |
| Quarterly EBITDA | $241.56M | -7.7% | +38.5% | +36.4% | -6.0% | |
| Price | $163.04 | -14.2% | -5.2% | -44.0% | -72.5% | |
| PE Ratio | 27.32 | -18.6% | -12.7% | -62.1% | -73.4% | |
| TTM Revenue | $4.10B | +1.5% | +2.9% | +10.6% | +45.5% | |
| TTM EPS | $5.97 | +5.5% | +8.6% | +47.6% | +3.7% | |
| $718.86M | +5.5% | +10.1% | +21.9% | +32.5% | ||
| TTM Net Income | $429.89M | +4.8% | +5.0% | +36.4% | -6.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $918.54M | at high | |
| 3Y | $918.54M | at high | |
| 5Y | $1.11B | -17.3% | |
| All | $1.11B | -17.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $793.41M | +15.8% | |
| 3Y | $741.73M | +23.8% | |
| 5Y | $663.93M | N/A | +38.4% |
| All | -$106.47M | +962.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ALGN?
As of today, ALGN TTM EBITDA is $918.54M
What is ALGN TTM EBITDA most recent change?
ALGN TTM EBITDA was up +7.89% on March 31, 2026
What is 1-year change in ALGN TTM EBITDA?
ALGN TTM EBITDA is up +14.23% year-over-year
How far is ALGN TTM EBITDA from its all-time high?
ALGN TTM EBITDA is currently -17.34% below its historical high of $1.11B set on December 31, 2021
How does ALGN TTM EBITDA rank versus sector peers?
ALGN TTM EBITDA is higher than 92.80% of companies in Healthcare sector
When is ALGN next earnings release?
The next earnings release for ALGN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ALGN Official Website www.aligntech.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1097149/000109714926000006/0001097149-26-000006-index.htm
- ALGN Profile on Yahoo Finance finance.yahoo.com/quote/ALGN
- ALGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/algn